Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008. by Dinç, G et al.
Dinç et al. BMC Public Health 2013, 13:896
http://www.biomedcentral.com/1471-2458/13/896RESEARCH ARTICLE Open AccessDecreasing trends in cardiovascular mortality
in Turkey between 1988 and 2008
Gönül Dinç1*, Kaan Sözmen2, Gül Gerçeklioğlu3, Hale Arık4, Julia Critchley5 and Belgin Ünal6Abstract
Background: Cardiovascular disease (CVD) mortality increased in developed countries until the 1970s then started
to decline. Turkey is about to complete its demographic transition, which may also influence mortality trends. This
study evaluated trends in coronary heart disease (CHD) and stroke mortality between 1988 and 2008.
Methods: The number of deaths by cause (ICD-8), age and sex were obtained from the Turkish Statistical Institute
(TurkStat) annually between 1988 and 2008. Population statistics were based on census data (1990 and 2000) and
Turkstat projections. European population standardised mortality rates for CHD and stroke were calculated for men
and women over 35 years old. Joinpoint Regression was used to identify the points at which a statistically
significant (p < 0.05) change of the trend occurred.
Results: The CHD mortality rate increased by 2.9% in men and 2.0% in women annually from 1988 to 1994, then
started to decline. The annual rate of decline for men was 1.7% between 1994–2008, whilst in women it was 2.8%
between 1994–2000 and 6.7% between 2005–2008 (p < 0.05 for all periods).
Stroke mortality declined between 1990–1994 (annual fall of 3.8% in both sexes), followed by a slight increase
between 1994–2004 (0.6% in men, 1.1% in women), then a further decline until 2008 (annual reduction of 4.4% in
men, 7.9% in women) (p < 0.05 for all periods).
Conclusions: A decrease in CVD mortality was observed from 1995 onwards in Turkey. The causes need to be
explored in detail to inform future policy priorities in noncommunicable disease control.
Keywords: Coronary heart disease mortality, Stroke mortality, Cardiovascular mortality, Trends, TurkeyBackground
By 2030, non-communicable diseases (NCDs) will account
for more than three-quarters of deaths worldwide. A recent
WHO report predicted that the Eastern Mediterranean Re-
gion would experience the largest increase in NCD deaths
between 2010 and 2020 (>20%) [1]. Globally, Cardiovascu-
lar Diseases (CVD) accounted for almost half (48%) of the
NCD deaths in 2008. CVD alone is responsible for more
deaths in low income countries than infectious diseases,
maternal and perinatal conditions, and nutritional disor-
ders combined [2]. An estimated 17.5 million people died
worldwide from CVD in 2005, representing 30% of all
deaths. Of these, 7.6 million were attributed to coronary
heart disease (CHD) and 5.7 million to stroke [3]. More* Correspondence: gonul.dinc@cbu.edu.tr
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reproduction in any medium, provided the orthan 80 percent of the CVD deaths occurred in low and
middle income countries. The World Health Organization
(WHO) estimates that there will be about 20 million CVD
deaths in 2015 globally [1]. The increasing burden of CVD
in low and middle income countries is mainly due to popu-
lation growth and ageing, in conjunction with the eco-
nomic transition and resulting increases in risk factors
such as obesity, insufficient physical activity, and tobacco
use [3]. Detailed analyses of time trends in cardiovascular
mortality, morbidity, risk factors and treatments are there-
fore now urgently required in such countries [1-3].
Mortality rates generally appear to be most closely
linked to a country’s stage of epidemiological transition.
As the economy, development status, and health systems
of these countries improve, the population moves to a
later stage of epidemiological transition, and chronic
NCDs become the predominant causes of death and dis-
ease [2]. Turkey has almost completed the “epidemiologicald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2458/13/896transition” [4]. Turkey has been going through a rapid
urbanization process since the early 1980s, with good
economic growth [5]. Because of the ageing population
and changes in lifestyle, morbidity and mortality from
CVD as well as other NCDs are increasing. However
population level data on causes of mortality in Turkey
are limited. A small cohort study carried out between
1990–2000 included 3687 participants from selected cit-
ies of Turkey. The crude CHD mortality rate for people
aged 45–74 years was found to be 800 per 100,000 in
men and 470 per 100,000 in women [6]. Lower CVD
mortality rates were estimated in the Turkish National
Burden of Disease Study (NBD) (2000); 352 per 100,000
in men and 317 per100 000 in women; stroke mortality
rates were 236 per 100,000 in men and 121 per 100,000
in women [7]. In the NBD Study CHD and stroke were
estimated to account for 36% of all deaths [8].
CHD or stroke account for most cases of CVD. In
Western populations and in Eastern Mediterrenean Re-
gion, most of the reported stroke cases are ischemic
stroke which shares a common aetiology with CHD [9].
There has been a consistent decline in CHD and stroke
mortality in developed countries since around the 1970s.
This reflects both a decrease in incidence due to im-
provements in population risk factors and better treat-
ments for patients with CHD and stroke [2,3]. However,
evidence from several Western countries suggests some
levelling out of CHD mortality rates among younger
men and women, and with warnings that CHD mortality
rates in these age groups may even be starting to in-
crease [10-13]. Such a detailed analysis of the CVD mor-
tality trend over time by age and sex has not been
completed in Turkey, and is needed to inform future
policy priorities in CVD prevention and control. This
study therefore quantifies trends in CHD and stroke
mortality rates between 1988 and 2008.
Methods
Data on the number of deaths from 1988 to 2008 by
year, sex, age (10 year age groups between ages 35–75+)
and cause of death (coded according to International
Classification of Diseases-8, ICD-8) were obtained from
the Turkish Statistical Institute (Turkstat) [14]. Although
a death reporting system has long been established in
Turkey, it is thought to have limitations on reporting
coverage and coding inaccuracy for the cause of death
[7]. Therefore the total number of deaths was inflated by
12% in men and 16% in women to account for under-
reporting of deaths, based on expert opinion used in
NBD Study [7]. In Turkey, data on causes of death were
collected only from urban settings, which comprise ap-
proximately 60%–75% of the total population over the
years 1988–2008 [15]. Therefore the total number of
deaths was estimated by inflating the urban numbersproportional to the rural population, simply assuming
the same mortality pattern exists in the rural area.
Coding inaccuracy is another important limitation of
the mortality data in Turkey [7,16]. A large number of
deaths were coded as “Ill defined (senility and symptom
related deaths)” or “other heart diseases”. The two cat-
egories accounted for approximately 43% to 63% of the
total deaths during the study period (see Additional
file 1: Table S1). These codes were re-assigned based
on a redistribution algorithm developed for the NBD
Study. Fifty percent and 10% of the “other heart disease”
were allocated to CHD and to the stroke deaths, respect-
ively [7]. Ill-defined causes (approximately 10 to 15% of
the total deaths) generally included deaths coded as senil-
ity and symptom related deaths. These were proportion-
ately reassigned to causes within CHD and stroke.
Population estimates by age and sex were based on
census data for 1990 and 2000, projections for 1995 and
2005, and address based population counting system for
2008. Since the actual population data were available
only for the years 1990, 1995, 2000, 2005 and 2008, we
interpolated the population for other years using linear
regression [15]. The first census in Turkey was carried
out in 1927. Following this, population censuses were
carried out every five years between 1935 and 1990, with
the 14th taking place in the year 2000. Population cen-
suses in Turkey were generally carried out over one day
by application of a curfew. The population (de facto
population) present within the boundaries of the country
on the census day is enumerated. In 2006, TurkStat
changed the method of population census to address
based population counting system in order to produce
more reliable and up to date information on population
size and distribution. The 2008 population based on ad-
dress based population counting system was found to be
consistent with the 1990 and 2000 population censuses
and population projections [17].
Age and sex specific CHD and stroke mortality rates for
men and women over 35 years of age were then calculated
annually from 1988 to 2008. Rates were age-standardised
to the Turkish population in 2008. To aid comparability
with international studies, the CHD and stroke mortality
rates (number of deaths/population × 100 000) were also
age-standardised to the European standard population
(1976) for both those over 35 years of age and those aged
45–74 years [18].
Joinpoint Regression Program version 3.5 was used to
identify the points at which a significant change of direc-
tion in the trend occurred for CHD and stroke mortality
between 1988–2008 [19]. For every period the linear
slope of the trend and p value of the final model of the
joinpoint regression analysis was tabulated. In these ta-
bles also the minimum and maximum observed num-
ber of deaths and the minimum and maximum observed
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population) were presented for every identified period.
Each joinpoint denotes a statistically significant (p < 0.05)
change in trend. Bayesian information criteria were used
to select the model that best fits the data.
Results
Age-adjusted trends in CVD mortality
The overall age-adjusted (European population) mortal-
ity rate for CHD increased from 1988 to 1994, by 2.9%
in men (p < 0.05) and 2.0% in women (p < 0.05) annually,
then it declined from 1994. The estimated annual rate of
decline for men was 1.7% between 1994–2008 (p < 0.05)
while it was 2.8% between 1994–2000 (p < 0.05) and
6.7% between 2005–2008 (p < 0.05) in women (Figure 1,
Table 1, Additional file 1: Table S3).
For stroke mortality, in both sexes, a declining trend
was observed between 1990–1994 (with an annual de-
cline of 3.8% in both sexes, p < 0.05), then slightly in-
creasing trend was observed between 1994–2004 (an
annual increase of 0.6% in men, 1.1% in women, p <
0.05), then an a declining trend was observed until 2008
(an annual fall of 4.4% in men, 7.9% in women, p < 0.05)
(Figure 1, Table 1, Additional file 1: Table S4).
Similar trends were found in the CHD and stroke age-
standardized (Turkish population 2008) mortality data
(Additional file 1: Table S3–S4).
Age- and sex-specific CHD mortality trends
Age- and sex-specific trends in CHD mortality were
similar to the overall CHD mortality trend. There was
an increase in the CHD mortality rate between 1988 and
1994 in most age groups in men (annual rate of increase
ranging from 2.3% to 6.7%, p < 0.05), except among
those aged 65 to 74. In women, increases were also ob-
served in most age groups (annual increase of 4.5% for0.0
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Figure 1 Age-standardised (European population) coronary heart dise
aged ≥35, 1988–2008.those aged 35–44, 3.5% for those aged 55–64, and 2.0%
for those aged 65–74, p < 0.05). After 1994, CHD mor-
tality rates decreased among all age groups; the annual
falls ranged from 1.5 to 4.7% in men (p < 0.05), and 1.8 to
6.1% in women (p < 0.05) except for among those over 75.
CHD mortality rates deceased by 2.9% annually between
2003–2008 in men and 8.7% annually between 2005–2008
among women over 75, p < 0.05 (Table 2, Figure 2).
Age- and sex-specific stroke mortality trends
In general a decline in stroke mortality was also seen in
men and women for most age groups. The annual rate
of decline varied between 1.3–7.5% for different time pe-
riods between 1988–2008 (p < 0.05 for all comparisons).
An increase in stroke mortality was seen between 1995–
2005 among those over 75 (annual 2.2% increase in men
and 3.5% increase in women, p < 0.05) (Table 3, Figure 3).
Discussion
CHD mortality rates increased from 1988 until 1994 in
Turkey, but have since been declining. The same trend
was also observed in stroke mortality rates. This is the
first study to analyze CVD mortality time trends over a
long (20 years) time frame in Turkey. Furthermore,
joinpoint regression analysis is able to identify periods
of similar annual percentage change in an objective man-
ner, to identify where the CVD epidemic “peaks” and then
declines.
Several limitations are attached to our results, and in
particular these concern the quality of mortality data.
Both the coverage and quality of the death reporting sys-
tem are considered relatively poor in Turkey [7,16].
However, the declining CVD mortality trend starting
from the mid 1990s is thought to be real since there
were no operational changes in the death reporting sys-
tem during that period. Data quality indicators such asCHD-Men
CHD-Women
Stroke-Men
Stroke-Women
ase (CHD) and stroke mortality in Turkey for men and women
Table 1 Change in coronary heart disease and stroke mortality by sex in Turkey for adults aged ≥35, 1988–2008
Sex Coronary heart disease Stroke
Identified periods Estimated annual percentage change
(95% CI)
Identified periods Estimated annual percentage change
(95% CI)
Men 1988–1994 2.9*(1.1,4.7) 1988–1990 2.0(−4.1,8.4)
1990–1994 −3.8*(−6.7, −0.4)
1994–2008 −1.7*(−2.0, −1.4) 1994–2004 0.6*(0.2,1.2)
2004–2008 −4.4*(−6.3, −2.6)
Women 1988–1994 2.0*(0.2–3.7) 1988–1990 3.6(−4.9,12.8)
1994–2000 −2.8*(−5.0, −0.5) 1990–1994 −3.8(−7.8,0.4)
2000–2005 1.0(−2.2,4.3) 1994–2005 1.1*(0.4,1.8)
2005–2008 −6.7*(−11.3, −1.8) 2005–2008 −7.9*(−11.8, 3.4)
*Linear slope of the identified period is significantly different from previous or next identified period (p < 0.05).
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other heart disease) also support this finding. During the
entire period (1988 to 2008) the proportion of senility,
symptoms and other heart disease codes were relatively
stable in men and women (ranging from 43–53% and
52–63%, respectively) (Additional file 1: Table S1). In
addition estimated total mortality rate during this period
looks stable but the proportion of CVDs in all deaths de-
creased slightly (Additional file 1: Table S2).
We estimated cause specific death rates between 1988–
2008 for 10 year age bands in trend analysis. It would
be desirable to analyse trends in narrower age bands.Table 2 Coronary heart disease mortality trends by sex and a
Men
Identified periods Estimated annual percentage chang
(95% CI)
35–44 1988–1994 3.9(1.0, 6.9)*
1994–2003 −4.7(−6.2, −3.2)*
2003–2008 −1.6 (−4.5, 1.4)
45–54 1988–1994 3.6 (2.2, 5.1)*
1994–2008 −2.7(−3.0, −2.4)*
55–64 1988–1991 0.9(−2.4,4.3)
1991–1994 6.7(0.1,13.7)*
1994–1999 −4.3(−6.2, −2.4)*
1999–2008 −2.4(−2.9, −1.9)*
65–74 1988–1994 1.7(−0.2,3.7)
1994–2008 −1.5(−1.9, −1.1)*
75+ 1988–1994 2.3(0.7–3.9)*
1994–1997 −4.5(−12.8,4.7)
1997–2003 0.9(−1.0,2.9)
2003–2008 −2.9(−4.4, −1.3)*
*Linear slope of the identified period is significantly different from previous or nextHowever, the Turkish Statistical Institute could only pro-
vide mortality statistics by 10 year age groups [14].
In estimating the mortality rates we assumed that
coverage of mortality data between 1988–2008 was 88%
for men and 84% for women. This assumption was based
on expert opinion [8]. Population surveys have also found
similar coverage levels [20].
The method we used to estimate mortality rates is ra-
ther simplistic, however our estimates for CHD and
stroke mortality rates for year 2000 are consistent with the
NBD Study where data from routine mortality statistics,
verbal autopsy and expert opinion were used to estimatege group in Turkey between 1988–2008
Women
e Identified periods Estimated annual percentage change
(95% CI)
1988–1994 4.5(1.0, 8.1)*
1994–2000 −6.1(−9.8, −2.3)*
2000–2008 0.2(−1.6,2.0)
1988–1990 8.6 (−6.6, 26.2)
1990–2008 −1.8(−2.2, −1.4)*
1988–1994 3.5(0.6,6.6)*
1994–2008 −3.2(−3.9, −2.5)*
1988–1995 2.0(0.4, 3.8)*
1995–2001 −3.2(−5.4, −0.9)*
2001–2006 −0.3(−3.3,2.8)
2006–2008 −4.8(−13.3, −4.6)*
1988–1994 1.5(−0.4,3.4)
1994–1998 −3.6(−8.5,1.6)
1998–2005 1.6(−0.1,3.2)
2005–2008 −8.7(−12.2, −5.1)*
identified period (p < 0.05).
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Figure 2 Observed and modelled coronary heart disease (CHD) mortality rate per 100 000, by age group for men and women,
1988–2008.
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http://www.biomedcentral.com/1471-2458/13/896the number and causes of deaths [7]. In our study the esti-
mated CHD mortality rate for those over 35 years was
374.4 per 100,000 in men and 310.2 per 100,000 in women
(Additional file 1: Table S3), comparable with the estimates
of 352.1 per 100,000 in men and 316.7 per 100,000 in
women in the NBD Study [7]. But we underestimated
stroke mortality by approximately 60 per 100,000 in men
(171 vs 236), and by approximately 30 per 100,000 in
women (184 vs 212) compared with the estimates of NBD
study (Additional file 1: Table S4). The differences may be
due to our assumption about the similarity of urban and
rural places. The TurkStat definition of urban and ruralarea is based on population size in a given settlement
(urban defined as a population over 20,000). However this
definition may not capture differences in social, economic,
access to health care or other epidemiologic aspects of
health outcomes [21]. The “real rural” population that has
higher mortality risk and poor access to health care is ra-
ther small and may not have a large impact on national
mortality statistics. In the NBD study higher mortality rates
were estimated in rural areas using sophisticated models.
Although only 35% of the population live in rural areas,
the NBD estimated that 45% of the CHD deaths, and 48%
of the stroke deaths occured in rural places [7]. This may
Table 3 Stroke mortality trends by sex and age groups in Turkey between 1988–2008
Men Women
Age groups Identified periods Estimated annual percentage change
(95% CI)
Identified periods Estimated annual percentage change
(95% CI)
35–44 1988–1999 −3.5(−4.3, −2.7)* 1988–2008 −3.3(−3.8, −2.9)*
1999–2002 −7.3(−16.6,3.1)
2002–2005 2.6(−8.8, 15.4)
2005–2008 −7.5(−12.0, −2.7)*
45–54 1988–1999 −2.2(−3.0, −1.5)* 1988–2005 −2.6(−3.2, −2.0)*
1999–2008 −3.8(−4.6, −3.0)* 2005–2008 −7.4(−13.7, −0.5)*
55–64 1988–1993 −3.0(−5.0, −1.0)* 1988–1999 −0.8(−1.7,0.1)
1993–1996 1.9(−6.9,11.5) 1999–2008 −5.2(−6.2, −4.1)*
1996–2008 −3.9(−4.3, −3.4)*
65–74 1988–1995 −2.6(−4.1, −1.1)* 1988–1999 0.4(−0.3,1.1)
1995–1998 3.3(−6.1,13.7) 1999 − 2006 −1.6(−3.1, −0.1)*
1998–2006 −1.3(−2.5, −0.1)* 2006–2008 −7.5(−15.3,1.0)
2006–2008 −5.8(−13.8, −3.0)*
75+ 1988–1990 3.2(−7.0,14.5) 1988–1996 −2.1(−3.6, −0.6)*
1990–1995 −3.2(−6.3, −0.0)*
1995–2005 2.2(1.3 − 3.1)* 1996–2005 3.5(2.1–5.0)*
2005–2008 −4.4(−8.0, −0.8)* 2005–2008 −8.6(−13.2, −3.8)*
*Linear slope of the identified period is significantly different from previous or next identified period (p < 0.05).
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http://www.biomedcentral.com/1471-2458/13/896be a slight overestimation, since life expectancy at 60 years
was only 1 year longer in urban compared with rural areas
(18.4 in urban vs 17.2 in rural) [8].
Studies show that urbanization has both positive and
negative impacts on cardiovascular mortality. The urban
population is wealthier and has greater access to treat-
ment. However the urbanization is generally associated
with an increase in tobacco use, obesity, some aspects of
an unhealthy diet, and a decline in physical activity [3].
On the other hand rural populations may have poor ac-
cess to health care. Therefore the urban and rural mor-
tality CVD patterns in Turkey are not clear. If CVD
mortality is higher in rural areas as suggested in the
NBD study [7], an underestimation of CVD mortality is
likely in our study, especially at the beginning of the
time period since the proportion of rural population de-
creased from 40% to 25% between 1988 and 2008 [15].
We estimated age-adjusted (European population)
CHD mortality rates for those aged 45–74 as 469.2 per
100,000 in men and 266.0 per 100,000 in women in
2000. Age-adjusted (European population) stroke mor-
tality rates aged 45–74 were calculated as 211.0 per
100,000 in men and 172.8 per 100,000 in women in
2000. Despite the declines since 1994, Turkish CHD and
stroke mortality rates are still ranked in the top quartile in
Europe both among men and in women. Turkish mortality
rates are higher than those in Central European countries
such as Hungary or the Czech Republic, and lower thanthose in Eastern Europe countries such as Lithuania and
Estonia (Additional file 1: Table S3–S4) [21]. For example,
the age standardised CHD mortality rates for those aged
45–74 (European population) were 529 per 100,000 in
men and 202 per 100,000 in women in Hungary, while
they were estimated as 713 per 100,000 in men and 260
per 100,000 in women in Estonia. The age standardised
stroke mortality rates were 254 per 100,000 in men and
125 per 100,000 in women in Hungary, while they were
487 per 100,000 in men and 248 per 100,000 in women in
Estonia [22].
In Turkey, high cardiovascular mortality may be due
to a high prevalence of cardiovascular risk factors like
smoking, hypertension, obesity and low mean HDL chol-
esterol levels. According to the results of latest nation-
wide surveys on adult population, smoking prevalence
was 48% in men and 15% in women [23]; hypertension
prevalence was approximately 30% in both sexes [24];
obesity prevalence was 13% in men and 33% in women
[24]; low HDL-C prevalence was 25.2% in men and
32.4% in women [25].
The high cardiovascular mortality of the Eastern and
Central European countries is mostly explained by the
risk factors such as high smoking rate and high alcohol
comsumption, as well as the poor treatment quality and
low welfare level [26].
Since the 1970s, a continuous decrease in CHD mor-
tality rates has occurred in Western Europe. In Central
Figure 3 Observed and modelled stroke mortality rate per 100 000, for men and women by age group, 1988–2008.
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http://www.biomedcentral.com/1471-2458/13/896and Eastern Europe, CHD mortality rates increased until
the early 1990s and decreased thereafter [22,27-29]. In
Turkey, the decreasing trend in CHD mortality started
from 1994 as in other Central and Eastern European
countries. The rate of decline in these countries in the
1990s was much faster than the rate of decline in Western
Europe in the 1970s. From the early 1990’s, important de-
creases in CHD mortality rates (approximately 2% per year
in Poland and Hungary, approximately 6% per year in the
Baltic states) were noted. In our study we estimated thataverage decline for men was 1.7% between 1994–2008
while it was 2.8% between 1994–2000 and 6.7% between
2005–2008 in women. In Western Europe, the average
annual decline reported was approximately 2% (55% abso-
lute decrease in CHD mortality) between 1970 and 2000
[22,29]. Stroke mortality time trends in western and cen-
tral/eastern part of Europe and Turkey are similar to the
CHD mortality trends [22]. Evidence is accumulating that
the early declines in cardiovascular mortality (especially
CHD) are, to a large extent, due to changes in diet and
Dinç et al. BMC Public Health 2013, 13:896 Page 8 of 9
http://www.biomedcentral.com/1471-2458/13/896lifestyle factors. The more recent declines in Western
Europe and the USA are also due to improvements in
secondary prevention through risk factor lowering in pa-
tients and the improvements in modern cardiovascular
treatment [27,28,30,31]. The recent impressive decline in
CHD mortality in Eastern European countries are also
explained by the improvements in three major risk fac-
tors such as a decrease in the percentage of smokers and a
decrease in average serum cholesterol and blood pressure
levels [22,29,32]. The decreasing trend in cardivascular
mortality rate after early 1990s in Turkey may also origin-
ate from increased uptake of effective treatments [33]. Des-
pite substantial decreases in CVD mortality in Central and
Eastern Europe, as well as in Turkey, these countries still
have high CVD mortality rates [22].
A slowing of the decline in coronary heart disease
mortality is now occurring in young adults (under 55) in
developed countries including Australia, America, the
UK and Holland [10-13]. In contrast, we found similar
decreases in mortality in both younger and older age
groups in Turkey. But this finding from developed coun-
tries is important and requires further analyses in order
to tailor and sustain community based programmes to
reduce CVD risk factors and hence CHD mortality in
the future in Turkey.
In the absence of a known denominator population,
the relative contributions of CHD and the stroke to car-
diovascular mortality can be measured by the ischemic
heart disease (e.g. CHD) to cerebro vascular accident
(e.g. stroke) death ratio (the IHD to CVA ratio, ICR)
[3,16]. We calculated ICRs between 1988–2008 based on
the estimated mortality rates; the range was 2.0–2.7 in
men and 1.6–2.2 in women (Additional file 1: Table S5).
These results broadly agree with other studies from
Turkey. Razum estimated a slightly higher ICR (2.0)
based on hospital data in Turkey from 1993–1998 [16],
and the NBD study estimated slightly lower ICRs; 1.4
for men, 1.5 for women [7]. ICRs in western developed
countries are approximately 3 (e.g. Finland 2.7, Germany
3.2, UK 3.1 and USA 3.8) whilst in China and Japan they
are 0.5 and 1.0 respectively [34]. These results suggest that
the epidemiology of cardiovascular diseases in Turkey
more closely resembles the pattern of Western Europe,
with higher ischaemic heart disease mortality than for
stroke than that for countries of East Asia, where stroke
predominates.
Conclusion
A decreasing CVD mortality trend was observed from
1994 in Turkey, based on routine statistics. The causes
need to be explored in detail to inform future policy pri-
orities in noncommunicable disease control. There is
also an urgent need to strengthen death registration and
other health information systems in Turkey. These willyield valid and reliable statistics for health policy plan-
ning and evaluation.
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